Lisa Fortin

Lisa Fortin has extensive experience in the field of clinical research and operations. Lisa is currently the Director of Clinical Operations at TransCode Therapeutics, Inc., a position they have held since August 2022.

Prior to their current role, Lisa worked as a Senior Clinical Trial Lead at ERYTECH Pharma from July 2020 to August 2022. Before that, they served as a Senior Clinical Study Manager at RENEURON LIMITED from May 2019 to October 2019.

Lisa also held the position of Senior Clinical Project Manager at Karyopharm Therapeutics Inc. from October 2017 to March 2019 and Senior Clinical Trial Manager at EMD Serono, Inc. from January 2013 to October 2017.

Their previous experience includes roles such as Senior Clinical Research Specialist/Clinical Project Lead at Johnson & Johnson from April 2011 to January 2013, Senior Clinical Research Associate at Rhode Island Hospital from October 2005 to April 2011, Clinical Trial Manager at RenaMed Biologics, Inc. from 2003 to 2006, and Clinical Scientist at Wyeth from August 2001 to July 2003.

Overall, Lisa Fortin has a strong background in clinical research and has held various managerial positions throughout their career.

Lisa Fortin received their BS and MS degrees in Biology, Biotechnology & Management from Salve Regina University from 1992 to 1998.